Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2021-09-14 00:00:00 ET · period of report 2021-09-10 · accession 0001209191-21-056093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-14 | 2021-09-13 | CRSP | KASINGER JAMES R. | GC, Sec | F - Tax | $117.86 | -4,741 | 29.2K | -14% | -$558.8K |
| D | 2021-09-14 | 2021-09-10 | CRSP | KASINGER JAMES R. | GC, Sec | M - OptEx | — | +10.0K | 33.9K | +42% | — |
| D | 2021-09-14 | 2021-09-10 | CRSP | KASINGER JAMES R. | GC, Sec | D - Sale to Iss | — | -10.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2021-09-13 | F | D | 4,741 | $117.86 | 29,170 | D | — | — | |
| 2 | Common | Common Shares | 2021-09-10 | M | A | 10,000 | — | 33,911 | D | — | — | (F1) The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021. (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. |
| 3 | Derivative | Restricted Stock Units | 2021-09-10 | D | D | 10,000 | — | 0 | D | — · — to — | 10,000 Common Shares | (F2) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. (F1) The restricted stock unit award was granted on September 10, 2019 with respect to 10,000 Common Shares, with all shares vesting on September 10, 2021. |